Upstream Bio Reports Positive Top-line Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma
February 11, 2026 06:00 ET | Source: Upstream Bio – Verekitug provided…
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) today…
AscellaHealth Expands International Operations, Broadens Executive Leadership to Accelerate Global Market Access for Life Sciences
DUBLIN and BERWYN, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- AscellaHealth, a…
BioAro Secures UAE Approval for AI-Enabled Longevity Bioactives, Setting the Stage for Global Expansion
DUBAI, United Arab Emirates and TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) --…
Tecan to host Analyst and Media Conference with Capital Markets Update on March 16, 2026
Männedorf, Switzerland, February 10, 2026 – The Tecan Group (SIX Swiss Exchange:…
Hassan Spine & Sports Medicine Rebrands as NefraHealth
New Identity Reflects Patient-First Philosophy, Practice Growth Board-Certified Spine Surgeon Joins Growing…
Age Verification Enters a Stage of Audits, Enforcement, and Penalties
RESTON, Va., Feb. 10, 2026 (GLOBE NEWSWIRE) -- As age checks move…
Token Security is a Top 10 Finalist for RSAC 2026 Innovation Sandbox Contest
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Token Security, the leader…
Geordie AI Selected as Top 10 Finalist for RSAC 2026 Conference Innovation Sandbox Contest
Geordie AI Selected for Monitoring and Governing AI Agents in Real Time…
Ipsen – January 2026 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…
